Pioneering precision analytical chemistry, multi-target chromatographic fingerprinting, and rigorous ICH Q2(R1) validation frameworks for natural botanicals, nutraceuticals, and active pharmaceutical ingredients (APIs).
Send Inquiry NowPrecision chromatographic profiling and clinical-grade validation matrices tailored to Turkish pharmaceutical manufacturers and global herbal extract CDMO standards.
Full HPLC/UPLC and MS/MS multi-component assay development for herbal matrices.
Explore Validation Scope
Bridging bioequivalence and clinical pharmacology dossiers for TITCK and EMA filing.
View Clinical Workflow
Comparative secondary metabolite profiling across Mediterranean and Aegean eco-zones.
Inspect Sourcing Models
GLP-compliant toxicological screening, dose-range determination, and in-vivo validation.
Examine Safety AssaysTurkey’s geographic positioning links EMEA demand with diverse Anatolian phytochemistry, creating a high-stakes requirement for internationally harmonized testing protocols.
The Turkish Ministry of Health (TİTCK) enforces stringent compliance with European Pharmacopoeia (Ph. Eur.) guidelines. Turkish manufacturers in Istanbul, Kocaeli, and Tekirdağ are shifting rapidly toward localized production of biosimilars, phytopharmaceuticals, and standardized phytotherapeutics, requiring method transfer protocols that resist batch variation.
With strategic customs unions and bilateral accords, Turkish contract manufacturing companies export to over 150 nations. Ensuring reliable quantitative determinations of active markers (such as polyphenols, ginsenosides, and flavonoids) guarantees zero-friction customs entry and frictionless regulatory clearance across both EU and MENA regulatory corridors.
Turkey hosts more than 3,000 endemic botanical taxons. Unlocking their commercial value as active ingredients demands specialized chromatography: separating enantiomers, mapping volatile terpenoids, and quantifying secondary metabolites affected by variable soil chemistry and seasonal Mediterranean microclimates.
An engineering-grade methodology adhering to ICH Q2(R1/R2) standards, eliminating co-elution, Matrix interferences, and peak distortion in complex organic molecules.
We initiate by formulating an Analytical Target Profile (ATP) aligning with target dosage specifications. Scouting phases evaluate stationary phase chemistries (C18, HILIC, Phenyl-Hexyl, Chiral selectors) and mobile phases (acidic/basic buffering, organic modifiers) under gradient conditions to achieve critical peak resolution (Rs > 1.8) for all primary isomers.
Every analytical method must demonstrate stability-indicating capabilities. We submit raw substrates and formulated products to extreme thermal stress, photolytic irradiation, acid/base hydrolysis, and oxidative conditions. Mass spectrometry coupling (LC-MS/MS, Q-TOF) confirms that degradation pathways do not mask target active molecules.
We execute exhaustive validation: Linearity (R² ≥ 0.999), Precision (Repeatability and Intermediate Precision with RSD < 2.0%), Accuracy (Spike recovery within 98.0%-102.0%), Specificity/Selectivity against placebo blanks, and Limit of Detection/Quantitation (LOD/LOQ) down to microgram/nanogram thresholds.
A method established in our high-containment R&D center is engineered for frictionless deployment into Turkish industrial QC environments. We supply Comparative Testing Protocols, standard reference substances, system suitability metrics, and re-qualification acceptance thresholds to ensure zero discrepancies upon technology transfer.
| Analytical Dimension | Primary Analytical Modality | Acceptance Baseline | Industrial Standard Alignment |
|---|---|---|---|
| Polyphenol & Glycoside Fingerprinting | UHPLC-DAD / ESI-Q-TOF-MS | Similarity Coefficient > 0.95 vs reference standard | Ph. Eur. / USP <203> |
| Residual Volatile Solvents | Headspace GC-MS / GC-FID | Meets Class 1, 2, 3 residual limits (ICH Q3C) | ICH Q3C (R8) |
| Heavy Metal Speciation (As, Cd, Pb, Hg) | ICP-MS (Dynamic Reaction Cell) | Sub-ppb limits; recoveries within 90–110% | USP <232> / <233> |
| Pesticide Multi-Residue Testing | LC-MS/MS & GC-MS/MS (QuEChERS) | Compliant with 500+ compounds threshold | EU No 396/2005 |
Combining 14+ years of TCM modernization with automated pilot-to-commercial extraction centers to guarantee consistent supply, stable cost structures, and uncompromised QC reproducibility.
Our industrial base in Changsha, China, spans continuous multi-stage countercurrent extraction, nanofiltration, and low-temperature freeze-drying. By deploying process analytical technology (PAT) and in-line NIR sensors, our processing ensures that batch extraction directly mirrors analytical specifications established in the laboratory.
All herbal and botanical supplies undergo strict provenance audits. From harvest coordinate registration to chromatography barcodes tied to each production run, every drum of active ingredient delivered to Turkish ports carries an auditable analytical dossier ensuring audit readiness before international health authorities.
Leveraging scale, high-throughput testing systems, and proprietary solvent recovery networks, we drive manufacturing conversion costs down by up to 35% compared to fragmented suppliers. This margin resilience equips Turkish OEM/CDMO brands with significant competitive price advantages in export markets.
Meeting the strict documentation expectations of global pharmaceutical and functional nutrition procurement teams.
Our analytical method reports are supplied in pre-structured Common Technical Document (CTD) Module 3 format (3.2.S.4 and 3.2.P.5). Turkish sponsors can integrate our validation data, chromatograms, precision readouts, and degradation summaries directly into submissions for TİTCK registrations or EMA dossiers without reformatting.
Under our strict CRO contract framework, intellectual property developed during analytical method establishment belongs exclusively to the commissioning client. Proprietary formula constituents, non-public extraction sequences, and specialized mobile phase additives are secured under bilateral non-disclosure agreements, backed by audited digital access segregation.
Select our turnkey contract research options or discrete analytical assay packages to bolster your ongoing production and compliance cycles.
Method establishment, forced degradation assays, and validation reports.
Access Method Protocols
Full-phase human clinical trial design, monitoring, and statistical reporting.
View Clinical Scope
Active yield optimization across regional habitats and climate windows.
Inspect Sourcing Framework
Acute LD50, repeated-dose sub-chronic, and organ-specific toxicity profiling.
Review Preclinical Models
Bioactivity-guided fractionation, molecular affinity, and target discovery.
Examine Screening Matrix
Tailored HPTLC, SFC, and UPLC assay designs for challenging complex botanicals.
Review Analytical Suite
Mechanistic receptor interaction, enzymatic inhibition, and cell survival assays.
Investigate Bioassays
Direct Ph. Eur., USP, and TİTCK compendial alignment and transfer validation.
Explore Compendial AssaysClear, authoritative insights for R&D Directors, QC Managers, and Sourcing Heads operating across Turkey and international jurisdictions.
Connect with our analytical chemistry team to receive a feasibility study, protocol outline, or customized CDMO quotation for your plant extract, drug substance, or functional product.
Send Inquiry Now